Register
Login:
Share:
Email Facebook Twitter

SAR Share Chat - RSS Feed

Sareum Share Chat (SAR)



Share Price: 0.55Bid: 0.50Ask: 0.60Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.10Spread as %: 20.00%Open: 0.55High: 0.60Low: 0.55Yesterday’s Close: 0.55



Share Discussion for Sareum (SAR)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


wintzy
Posts: 222
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.60
maytheforce
26 Feb '14
Is this connected to SAR?
 
maytheforcework
Posts: 3,448
Off Topic
Opinion:No Opinion
Price:0.60
Daily Mail today
26 Feb '14
Patient treated for cancer on a trial at Manchester hospital showed positive results in 12 weeks.So we may get some results from China soon.
bobsbargains
Posts: 197
Off Topic
Opinion:No Opinion
Price:0.60
Great positive news
26 Feb '14
great positive news now just a waiting game . good luck to all long term investors.
bobsbargains
Posts: 197
Off Topic
Opinion:No Opinion
Price:0.60
View Thread (2)
RE: load of rubbish
26 Feb '14
you really need to do research tim and co are sar if you replace them there is no sar !!!!!
shepster
Posts: 5
Off Topic
Opinion:No Opinion
Price:0.60
PCS1954
26 Feb '14
Couldnt agree more. Frustrating that this is taking so long to pull back to a decent level but we are heading in the rght direction, will take time, but we seem to have the right partners to do this with.
There has been far to much ramping and building peoples expectaions up.
Keep the faith and as always DYOR
jamster
Posts: 1,571
Off Topic
Opinion:No Opinion
Price:0.60
No surprises
26 Feb '14
Oh well, didn't expect any to be honest. Now will be the time to start building a good position again.
DrRocky
Posts: 180
Observation
Opinion:Strong Buy
Price:0.60
Answerpoint - losses?
26 Feb '14
1. Which 'competent team' do you wish the current management team to be replaced with? I though SAR only had 2 employees? I may be wrong since my info on that point is a bit dated. They may have increased their staffing by 50%. Therefore 3 employees.
2. Have you done your research?
3. Are you bitter and twisted because you jumped in a few years ago and lost money?

Looks like I am holding for longer but thats the risk of any share.
Londonwolfie
Posts: 445
Off Topic
Opinion:No Opinion
Price:0.60
View Thread (2)
what did I learn today
26 Feb '14
As TalkingSense sensibly says, the starting point for me is that there was no bad news.

CHK1- nothing really new from the patent update end-Jan and previous news. The final paragraph, where it states that "the directors note with interest recent reports in scientifdic literature", could have been written much better in my view, simply by adding what this could mean to Sareum's future plans rather than just leaving it hanging. Seems a missed opportunity in my humble opinion.

Aurora+FLT3 - nothing more to see here. Certainly not the fast track good news that a certain poster or two was expecting to be announced. But nothing at all that disappoints.

TYK2+JAK1 - thought there are some small positives here if digging deep enough. The promise of study results in scientific literature and conference presentations provides potential catalysts throughout the year. There are so many conferences that it is impossible to narrow these down but we may see Tim at the big dermatology/psoriasis conferences in Miami/San Diego before too long!

So overall, a bit of a damp squib if truth be known but nothing that makes me too disappointed. Slowly slowly catch the monkey and all that. This time next decade Rodney......

Think there may be some disappointment from those who were "street wise enough to know that something was going on behind the scenes" by the fact that there is very limited fundamental improvement to drive the SP higher based on this update, whilst I think the majority of holders will continue to hold/accumulate when the more short-term focused investors bail. Ultimately, they may be right to bail - such is the nature of very junior biotech investing - but as stated, I'm not too surprised/disappointed by today's update.
PCS1954
Posts: 962
Off Topic
Opinion:No Opinion
Price:0.60
Morning All
26 Feb '14
So Sar in collaboration with CRUK one of the world's leading cancer research institutions, with China the world's biggest potential market, US patent for Skil platform - for a drug discovery company yeah they do sound a total mess-up lol.......me thinks some people didn't do too much research when they invested here.

Of course great risk as highlighted by many a positive poster on here, but any "discovery" company needs progress and thats what we got today no more no less......anyway off to the slopes now so GLA and DYOR
Answerpoint
Posts: 37
Off Topic
Opinion:No Opinion
Price:0.60
View Thread (2)
load of rubbish
26 Feb '14
I have been with SAR for over 2 years now and have now finally come to conclusion that this company is a total mess-up. The decisions, reassurances and false promises made by the management over the years have dragged the share price downwards. I am sure there are a lot of investors who are running out of patience with this company and its management for lack of direction and empty promises. Unless management including Tim is replaced by a more competent team I see no return in this share for at lest another 2-3 years. DYOR and good luck all.



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.